Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I was thinking the same exact thing
Sigh. I told you a couple months ago that I thought they would double/triple/quadruple down on their corruptness.
Guess I’ll take even harder to social media to do my part.
Also, *hundreds of thousands
How do you see it playing out?
These same thoughts ruminate with me as well. Coincidence he schedules a meeting the day after we announce a trial there?
I talked about the possibility of leronlimab being a functional cure for CCR5-tropic patients. Exciting news!
Over $100M+ in shares traded today. Someone pinch me.
Let me add one more
4) your warrants are about to expire and share price is higher than strike price
To be honest, I’m not entirely sure. I understand the science (sort of) more than I know about the intricacies of publicly traded companies. It shouldn’t affect share price unless those warrant holders turn around and try and sell their shares after they exercise them? What I do know is that all of the cash from those exercised warrants will help to prevent future dilution.
At what point does every warrant holder say, “okay, I’ll exercise them now” ?
Agreed with Blane and FooBar’s posts. Also, I would suggest having a discussion with their respective treating physicians whose care they are under about leronlimab. It will ultimately be their decision what direction they want to go with treatment.
Not sure what he has to do with HCQ being proven to be ineffective.
Is Dr. Bruce Patterson wrong?
You’ll notice that she likes to reference sources like these - discredited chiropractors, anti-vaxxers, conspiracy theorists, etc. You won’t find any posts with information that can be referenced and verified.
Not sure, but they would probably have tons of sugar in them.
Chronic consumption of aderall will cause insomnia too.
A stroke can cause misspeak.
I guess we can take HIV revenue off our evaluation:
https://www.google.com/amp/s/news.yahoo.com/amphtml/trump-falsely-suggests-aids-vaccine-170529427.html
And yet you still can’t post a clinical study proving efficacy. Remember; anecdotes don’t count.
Also, maybe leave race out of your posts?
Even a broken clock is right twice a day. Now they just have to rectify their decision to approve remdesivir, and approve leronlimab.
Probably have a lot more to worry about than CYDYs share price.
Yes. Yes. Yes. Leronlimab will disrupt billions of dollars in revenue for multiple big pharmaceutical companies. The FDA and other corrupt figures are my only concern for CytoDyn.
Hydroxychloroquine still doesn’t work in case anyone was interested:
https://www.sciencemag.org/news/2020/06/three-big-studies-dim-hopes-hydroxychloroquine-can-treat-or-prevent-covid-19
Would a hammer like leronlimab have any effect on the kind and degree of inflammation in a cold?
If so, would it interfere with the natural, healthy immune response to a significant degree, making the disease worse?
I don't think that is at all obvious. If a hammer is not needed to knock out CRS and you use a much lower dose, would there be any effect on CD8+? Would there be any (beneficial) effect on viral load in nose or throat tissues? In critical covid-19 cases, the effect is in reducing plasma viral load. Is viremia common with a cold? I'm dubious.
Dr P has suggested using highly elevated RANTES levels as a diagnostic tool for evaluating when the disease has progressed from what he calls the viral stage to the immune stage where leronlimab would be expected to exert its a beneficial effect via occupation or the CCR5's that RANTES binds to. What role would a CCR5 blocker have in the absence of a RANTES problem? [not talking HIV here, HIV is different]
Oh, so exclusion/inclusion criteria are the same for a drug that addresses different indications? That’s like saying that since Lovaza is safe for cholesterol patients, it must also be safe for patients that have a bleeding disorder.
We know HCQ is immunosuppressive, and the preponderance of data shows that in addition to HCQ not being beneficial, it is also causing harm in covid19 patients.
It’s one of the best performed trials on HCQ to date.. What’s wrong with the trial? It was a double blind trial where those taking HCQ were given it within 4 days of symptoms.
Just because you listed other drugs that might be more dangerous, does not negate HCQs negative effects in covid19 patients. This is well documented now.
Hydroxychloroquine does not prevent Covid-19, or slow disease progression. It also doesn't help recovery of the seriously ill. It does, however, increase the risk of heart disease and death:
https://www.wired.com/story/major-hydroxychloroquine-trial-shows-no-prevention-benefits/?utm_source=onsite-share&utm_medium=email&utm_campaign=onsite-share&utm_brand=wired
Sounds just like mine too.
I believe he can see the blinded data - just not who is receiving the placebo or leronlimab.
Opportunity cost. If you’re a trader, sure. If you’re an investor, CYDY will be the best payout long-term assuming we can navigate corrupt regulatory bodies.
Ignoring DD into the company - they were so lazy, that they couldn’t click from the 1d chart to the 6m chart.
Might be the one time I disagree with you here. If there’s one thing we’ve seen with recent events relating to covid19, it’s that people are more than willing to double down on their stupidity and corruption.
I think I’m finally up to speed here with the MoA and list of indications. Since we’re working with a CCR5 antagonist that does not disrupt normal immune function - you can add virtually every condition ending in ‘itis’ to this list. Inflammation is the cause of most, if not all age-related diseases, and since leronlimab restores immune/inflammatory homeostasis - there is a theoretical application for every inflammatory condition. A “generational drug”. Thoughts?
Exactly. Just like Gilead did with remdesivir.
This shouldn’t surprise too many people. Didn’t they stop an Ebola-remdesivir trial because of this exact reason?
Agreed. While I would like to have Dr. Bruce on the call, it is not a necessity, nor does it decrease credibility of the company. See you on Tuesday!
True - Dr. Nader deserves his share of the credit; however, if anyone deserves the majority though, it’s Dr. Bruce.
Dr. Bruce Patterson should get that medal.
Your statement, not mine:
Why demand anything not 'studied'?
when compared with mortality in the control group (9·3%), hydroxychloroquine (18·0%; hazard ratio 1·335, 95% CI 1·223–1·457), hydroxychloroquine with a macrolide (23·8%; 1·447, 1·368–1·531), chloroquine (16·4%; 1·365, 1·218–1·531), and chloroquine with a macrolide (22·2%; 1·368, 1·273–1·469) were each independently associated with an increased risk of in-hospital mortality.
Leronlimab is studied and has a very clear MoA for how it addresses covid19.
Why are suggesting that leronlimab isn’t studied? You can go to clinicaltrials.gov and see all of leronlimabs studies.